Pharmacogene Variation Consortium Gene Introduction: NUDT15.

Creator(s)

Jun J. Yang
Michelle Whirl-Carrillo
Stuart A. Scott
Amy J. Turner
Matthias Schwab
Yoichi Tanaka
Guilherme Suarez-Kurtz
Elke Schaeffeler
Teri E. Klein
Neil A. Miller
Andrea Gaedigk, Children's Mercy Kansas CityFollow

Document Type

Article

Publication Date

5-2019

Identifier

DOI: 10.1002/cpt.1268; PMCID: PMC6465081

Journal Title

Clinical pharmacology and therapeutics

Volume

105

Issue

5

First Page

1091

Last Page

1094

MeSH Keywords

Alleles; Biotransformation; Cytochrome P-450 Enzyme System; Genome-Wide Association Study; Haplotypes; Humans; Medication Therapy Management; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants; Pyrophosphatases; Terminology as Topic

PubMed ID

30515762

Keywords

Alleles; Biotransformation; Cytochrome P-450 Enzyme System; Genome-Wide Association Study; Haplotypes; Humans; Medication Therapy Management; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants; Pyrophosphatases; Terminology as Topic

Comments

Grants and funding

• R24 GM123930/GM/NIGMS NIH HHS/United States
• R24 GM061374/GM/NIGMS NIH HHS/United States
• R01 GM118578/GM/NIGMS NIH HHS/United States
• P50 GM115279/GM/NIGMS NIH HHS/United States

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Publisher's Link: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.1268

Recommended Citation

Yang JJ, Whirl-Carrillo M, Scott SA, et al. Pharmacogene Variation Consortium Gene Introduction: NUDT15. Clin Pharmacol Ther. 2019;105(5):1091-1094. doi:10.1002/cpt.1268